Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025 and Nov 2025.
- Largest single sale: $2.6M (34,664 shares) of Ionis Pharmaceuticals Inc on Oct 31, 2025. Filing
- Last sale before this period: Sep 30, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | EVP, Chief Development Officer | Aug 19, 2008 | Nov 7, 2025 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Nov 6, 2025, Ionis Pharmaceuticals Inc: sold 33,038 shares for $2.5M, under a disclosed plan; 33,038 shares acquired by exercising options. 1 filing: 1
- Nov 5, 2025, Ionis Pharmaceuticals Inc: sold 1,601 shares for $120K, under a disclosed plan; 1,601 shares acquired by exercising options. 1 filing: 1
- Nov 3, 2025, Ionis Pharmaceuticals Inc: sold 1,680 shares for $126K, under a disclosed plan; 1,680 shares acquired by exercising options. 1 filing: 1
- Oct 31, 2025, Ionis Pharmaceuticals Inc: sold 89,249 shares for $6.7M, under a disclosed plan; 69,249 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.